Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 925, pseudogene (RNU6-925P)** is a non-coding RNA gene classified as a *pseudogene* related to the U6 small nuclear RNA (snRNA) family[2][7]. U6 snRNA is essential for the catalytic activity of the major spliceosome, a complex responsible for removing introns from pre-mRNA in eukaryotes[1][3]. However, pseudogenes such as RNU6-925P are typically non-functional genomic sequences derived from functional snRNA genes[2][5][7]. Pseudogenes like RNU6-925P arise through retrotransposition and generally lack biological activity, protein products, or therapeutic relevance, but they play a role as markers of genome evolution and may reflect retrotransposition dynamics mediated by LINE-1 elements in the human genome[5][6][7]. There are no known disease associations, biological functions, drug interactions, or clinical uses attributed to this pseudogene[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 925, pseudogene (RNU6-925P).